|
Chembio Awarded Three-Year $3MM NIH SBIR Phase II Grant To Complete DPP(R) Test For Human Leptospirosis (Medical News Today) |
 |
 |
|
Chembio Diagnostic Systems, Inc. (a wholly-owned subsidiary of Chembio Diagnostics, Inc.) (OTCBB: CEMI) has been awarded a three-year $3 million Small Business Innovative Research (SBIR) Phase II grant from the United States National Institutes of Health (NIH) to fully develop, validate, and commercialize a rapid diagnostic test for leptospirosis for general use worldwide. read more |
|
Nouvelle clinique d'insuffisance rénale chronique à Sainte-Croix (L'Express/La Parole) |
|
|
|
Une clinique d'insuffisance rénale chronique vient de voir le jour à l'hôpital Sainte-Croix... read more |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
